Lokelma, an oral suspension powder, is available in a 5-gram packet. This medication is designed to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood [1].
What is Lokelma used for?
Lokelma is prescribed to lower high potassium levels in adults. It works by binding to potassium in the gastrointestinal tract, preventing its absorption into the bloodstream and promoting its excretion from the body [1].
How does Lokelma work?
The active ingredient in Lokelma is sodium zirconium cyclosilicate. When ingested, this compound selectively binds to potassium ions within the digestive system, effectively sequestering them. This binding action reduces the amount of potassium that can be absorbed by the body and facilitates its removal through feces [1].
How is Lokelma administered?
Lokelma is taken orally as a powder mixed with water. The typical dose is one 5-gram packet, but the dosage may be adjusted by a healthcare provider based on the individual's potassium levels and response to treatment [1].
What are the side effects of Lokelma?
Common side effects associated with Lokelma include diarrhea, nausea, and constipation. Patients should report any persistent or bothersome side effects to their doctor [1].
When does Lokelma's patent expire?
Information regarding the specific patent expiration dates for Lokelma is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [2].
Who makes Lokelma?
Lokelma is manufactured by AstraZeneca [1].
Are there alternatives to Lokelma for hyperkalemia?
Other medications are available to manage hyperkalemia, including potassium binders like patiromer and older treatments such as sodium polystyrene sulfonate. The choice of treatment depends on various factors, including the severity of hyperkalemia, patient tolerance, and physician recommendation [3].